Icelandair Group hf.
Icelandair Group has decided to initiate a process to sell its subsidiary Iceland Travel (the “company”). The decision is made in line with Icelandair Group’s strategy to focus on its flight operations, its core business. During the sales process, the objective will be to maximize the value of the company, while at the same time preserving the interests of Icelandic tourism, the company’s employees and other stakeholders.
Iceland Travel has been the leading travel company, tour operator and destination management company (DMC) in Iceland. The Company will continue to serve a key role in offering services to tourists in Iceland when the current conditions caused by the global pandemic will improve and demand for international travelling increases again. Following the pandemic, there will be a need for increased efficiency in the Icelandic tourism market and there are opportunities for Iceland Travel to be in a leading role as a comprehensive service provider for tourists.
Íslandsbanki will act as advisor to Icelandair Group and manage the sales process.
Contact information:
Investors: Iris Hulda Thorisdottir, Director Investor Relations. E-mail: iris@icelandairgroup.is
Media: Asdis Petursdottir, Director Communications. E-mail: asdis@icelandair.is
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Jiangxi Provincial Department of Culture and Tourism14.5.2025 07:34:42 CEST | Press release
"Tea for Harmony - Yaji Cultural Salon" and "Jiangxi Day" Promotion Event Held in Morocco
FLSmidth A/S14.5.2025 07:28:26 CEST | Press release
FLSmidth raises its full-year 2025 financial guidance
ABN AMRO14.5.2025 07:14:01 CEST | Press release
ABN AMRO Bank posts net profit of EUR 619 million in Q1 2025
Genespire14.5.2025 07:00:00 CEST | Press release
Preclinical insights into dosing for first-in-human in vivo liver-directed gene therapy for MMA delivered in an oral presentation at the ASGCT Annual Meeting
Marimekko Corporation14.5.2025 07:00:00 CEST | Press release
INTERIM REPORT OF MARIMEKKO CORPORATION, 1 January–31 March 2025: Marimekko’s net sales in the first quarter grew and operating profit was at a good level
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom